Moleculin Biotech Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
26 Dec 23 | BuyUS$129,999 | Walter Klemp | Individual | 12,560.27 | US$10.35 | |
26 Dec 23 | BuyUS$20,000 | Jonathan Foster | Individual | 1,932.4 | US$10.35 | |
26 Dec 23 | BuyUS$10,000 | Robert George | Individual | 966.2 | US$10.35 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 7,000 | 0.233% |
Individual Insiders | 93,278 | 3.11% |
Institutions | 170,606 | 5.68% |
Hedge Funds | 290,000 | 9.66% |
General Public | 2,441,011 | 81.3% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 51%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
290,000 | US$759.8k | 85.9% | 0.02% | |||
72,935 | US$191.1k | 29.6% | no data | |||
71,403 | US$187.1k | -15.4% | no data | |||
36,103 | US$94.6k | 6.96% | no data | |||
21,818 | US$57.2k | 10.4% | no data | |||
12,475 | US$32.7k | 0% | no data | |||
11,363 | US$29.8k | 0% | no data | |||
10,996 | US$28.8k | 0% | no data | |||
10,500 | US$27.5k | 0% | no data | |||
8,001 | US$21.0k | 0% | no data | |||
7,000 | US$18.3k | 0% | no data | |||
3,334 | US$8.7k | 0% | no data | |||
1,811 | US$4.7k | -9.22% | no data | |||
1,367 | US$3.6k | 0% | no data | |||
979 | US$2.6k | 0.1% | no data | |||
449 | US$1.2k | 5.4% | no data | |||
143 | US$374.4 | 472% | no data | |||
89 | US$232.8 | 0% | no data | |||
42 | US$110.1 | 0% | no data | |||
34 | US$88.9 | 0% | no data | |||
23 | US$60.6 | 0% | no data | |||
17 | US$44.8 | 0% | no data | |||
1 | US$2.4 | 0% | no data | |||
1 | US$2.4 | -83.3% | no data |